CD4 and myeloid sarcoma: Specifically, loss of STAT5 in CD4+ T cells resulted in decreased development of experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, relative to WT CD4+ T cells that produce GM-CSF normally [35].